Becton, Dickinson and Company (BD) is a leading global medical technology company that manufactures and sells medical supplies, devices, and diagnostic systems.
The Becton Dickinson bond, an obligation of the U.S.-based global medical technology company Becton Dickinson, identified by ISIN US075887BF51 and CUSIP 075887BF5, was originally issued in the United States as a USD 1,375,000,000 offering with a 3.734% coupon rate paid semi-annually (frequency of 2), a minimum purchase size of USD 2,000, and was last observed trading at 99.966% before its maturity on December 14, 2024, at which point it was fully repaid, having maintained investment-grade credit ratings of BBB from Standard & Poor's and Baa2 from Moody's.
|